The significant increase of HMGA2 positivity from non-invasive (5.9–18.2% positive) to invasive urothelial carcinomas (35.9–43.2%) is another example where HMGA2 upregulation is linked to cancer progression. Here, HMGA2 is linked to urothelial carcinoma.